Crouse Steven C. 4
4 · OmniAb, Inc. · Filed Jun 18, 2026
Research Summary
AI-generated summary of this filing
OmniAb (OABI) Director Steven C. Crouse Exercises Options & Receives RSUs
What Happened
Steven C. Crouse, a director of OmniAb, reported derivative activity and awards on 2026-06-17. The Form 4 shows: (a) an exercise/conversion of 20,000 derivative units resulting in acquisition of 20,000 shares (price N/A), (b) a related exercise/conversion/disposition of 20,000 derivative units with $0 reported proceeds, and (c) awards/grants of 20,000 and 40,000 Restricted Stock Units (RSUs) (total 60,000 RSUs) reported as acquired at $0. No cash proceeds or market sale proceeds are reported.
Key Details
- Transaction date: 2026-06-17; Form 4 filed 2026-06-18 (timely filing).
- Transaction codes: M = exercise/conversion of derivative; A = award/grant (RSUs).
- Reported share amounts: 20,000 (acquired via exercise/conversion), 20,000 (disposed at $0), and two RSU awards of 20,000 and 40,000 (total 60,000 RSUs).
- Reported prices/values: exercise/converted shares shown as N/A or $0; RSUs shown at $0 (typical for equity awards). No cash proceeds reported.
- Shares owned after transaction: not specified in the summary data provided here; see the full Form 4 for total post-transaction holdings.
- Footnotes of note:
- F1/F3: The RSUs relate to a grant on June 17, 2025 and vest on the earlier of the next annual meeting or the first anniversary of the grant.
- F2: Each RSU represents a contingent right to one share of common stock.
- F4: Stock options/derivatives referenced vest on a similar earlier-of schedule.
- Filing timeliness: filed the day after the transaction (no late filing flag indicated).
Context
- Derivative transactions (code M) indicate options or similar instruments were converted/exercised. The presence of a $0 disposition line alongside an acquisition line often reflects internal settlement mechanics (for example, net settlement or shares withheld to satisfy tax obligations), but the Form 4 does not specify the reason.
- RSU awards are not open-market purchases and reflect compensation/vested awards that convert to shares per the vesting terms; they do not necessarily signal a purchase decision by the insider.
- No sale-for-cash in an open market is reported; the filing documents equity awards and conversions rather than a discretionary purchase or sale.
For full holdings and precise post-transaction ownership, consult the filed Form 4 (Accession 0002065241-26-000005).
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1][F2]2026-06-17+20,000→ 33,333 total - Exercise/Conversion
Restricted Stock Units
[F2][F1]2026-06-17−20,000→ 26,667 total→ Common Stock (20,000 underlying) - Award
Restricted Stock Units
[F2][F3]2026-06-17+20,000→ 46,667 total→ Common Stock (20,000 underlying) - Award
Stock Option (right to buy)
[F4]2026-06-17+40,000→ 40,000 totalExercise: $2.03Exp: 2036-06-17→ Common Stock (40,000 underlying)
Footnotes (4)
- [F1]Represents the vesting of an RSU granted on June 17, 2025, which occurs on the earlier of (A) the date of the next annual meeting of the Company's stockholders following the grant date and (B) the first anniversary of the grant date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]The RSUs shall vest in full on the earlier of (A) the date of the next annual meeting of the Company's stockholders following the grant date and (B) the first anniversary of the grant date.
- [F4]Each Stock Option shall vest and become exercisable in full on the earlier of (A) the date of the next annual meeting of the Company's stockholders following the grant date and (B) the first anniversary of the date of grant.